Dr Julie Lamb | CureTalks
Julie Lamb, MD, FACOG is a board certified reproductive endocrinologist and infertility specialist at Pacific NW Fertility in Seattle and serves as clinical faculty at the University of Washington. Dr. Lamb is committed to combining state of the art technology and exceptional patient care to help patients meet their family building goals. She has presented and published over 50 peer-reviewed research projects at national meetings and is an active member board member of both the American Society of Reproductive Medicine patient education committee and embryo transfer committee and Pacific Coast Reproductive Society. She is also currently president of Seattle Gynecology Society. Dr. Lamb is dedicated to changing the conversation surrounding fertility care and strives to empower women to learn about their fertility options. Numerous awards, publications, and national presentations have honored her work. Recently, her randomized control trial of FSH at the time of hCG trigger was the prize paper presentation at ASRM’s national meeting, and the resulting paper has influenced clinical IVF protocols across the country. She is a recipient of a prestigious Fulbright Research Fellowship. Her interests span fertility preservation, ethnic disparities in IVF, improving IVF outcomes in women with diminished ovarian reserve and advanced age. Dr. Lamb graduated at the top of her class in biology and psychology from Seattle Pacific University, and completed her training in medical school at Northwestern University Fienberg School of Medicine in Chicago. Dr. Lamb completed her residency in Obstetrics and Gynecology at the University of Washington in Seattle, and did her fellowship in Reproductive Endocrinology and Infertility at University of California, San Francisco. As clinical faculty at the University of Washington she directs the REI training of Ob/Gyn resident physicians and is the Director of the Center for Fertility Preservation at Pacific NW Fertility.
Nearly 13000 women are diagnosed with cervical cancer in the United States each year and about 68% of all invasive cervical cancer cases…